Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gliogene: Brain Tumor Linkage Study

NCT00418899 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00418899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00418899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gliogene: Brain Tumor Linkage Study
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
February 12, 2004
Completion date
September 1, 2022
Enrollment
17,080 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, glioma